XBIO News | Roxom Stocks

1 BTC

- USD

Loading market data...

Mkt Cap

$4.7M

Volume

17.51K

Next Earnings

November 11th

Chart Financials Earnings News About Insider Filings

Xenetic Biosciences (XBIO) Reports Q1 Loss, Misses Revenue EstimatesXenetic Biosciences (XBIO) delivered earnings and revenue surprises of 1.27% and 21.39%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?Zacks Investment Research · May 10, 2024

Xenetic Biosciences (XBIO) Reports Q2 Loss, Tops Revenue EstimatesXenetic Biosciences (XBIO) delivered earnings and revenue surprises of 38.94% and 47.96%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?Zacks Investment Research · Aug 11, 2023

Oncternal Therapeutics (ONCT) Reports Q2 Loss, Lags Revenue EstimatesOncternal Therapeutics (ONCT) delivered earnings and revenue surprises of 11.76% and 49.52%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?Zacks Investment Research · Aug 10, 2023

Xenetic Biosciences (XBIO) Upgraded to Strong Buy: What Does It Mean for the Stock?Xenetic Biosciences (XBIO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).Zacks Investment Research · Jul 13, 2023

Lack Of Catalysts Prompts Analyst To Downgrade Xenetic BiosciencesHC Wainwright has downgraded Xenetic Biosciences Inc (NASDAQ: XBIO) from Buy to Neutral, citing pending clinical path visibility. In the Q1 earnings release, the company announced continued progress with the DNase-based oncology program toward Phase 1 study for pancreatic carcinoma and other locally advanced or metastatic solid tumors. Xenetic announced a one-for-ten reverse stock split, the second ...Full story available on Benzinga.comBenzinga · May 16, 2023

Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day SessionGainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash. 1847 Holdings LLC (NASDAQ: EFSH) gained 64.5% to $0.9050 after the company reported a 27.6% increase in revenue to $15.4 million and achieved profitability for the first quarter. Harbor Custom Development, Inc. (NASDAQ: HCDI) surged 49.5% to $8.97 following first-quarter results. WiSA Technologies, Inc. (NASDAQ: WISA) rose 47.4% to $2.33 after the company signed a Letter of Intent to acquire Comhear. WiSA expects acquisition to be accretive beginning in the fourth quarter and sees FY24 revenue of $10 million to $15 million. Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) gained 39% to $3.94 as the company said that its Chinese partner, HTIT, has successfully completed a Phase 3 oral insulin clinical trial and submitted a marketing authorization application in China. LM Funding America, Inc. (NASDAQ: LMFA) jumped 34% to $0.9816 following better-than-expected results for the first quarter. MGO Global, Inc. (NASDAQ: MGOL) shares gained 33.2% to $1.5910. MGO Global is scheduled to host a webcast on May 16, 2023 to discuss recent operational developments and financial results for the first quarter. Xenetic Biosciences, Inc. (NASDAQ: XBIO) jumped 24.8% to $4.12. Xenetic Biosciences recently announced a 1-for-10 reverse stock split. Sarepta Therapeutics, Inc. (NASDAQ: SRPT) gained 24% to $148.99 after the company announced the FDA voted in favor of its gene therapy to treat Duchenne muscular dystrophy late Friday. Multiple analysts raised price targets following the announcement. Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) surged 22% to $2.50. ZK International Group Co., Ltd. (NASDAQ: ZKIN) gained 21.7% to $0.7790. Peraso Inc. (NASDAQ: PRSO) shares climbed 18.1% to $0.4263. Peraso is expected to release its first-quarter financial results on May 15, 2023 after the closing bell. InspireMD, Inc. (NASDAQ: NSPR) jumped 18% to $1.71 as the company announced a ...Benzinga · May 15, 2023

Esperion Therapeutics (ESPR) Reports Q1 Loss, Tops Revenue EstimatesEsperion Therapeutics (ESPR) delivered earnings and revenue surprises of -21.54% and 15.71%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?Zacks Investment Research · May 9, 2023

Collegium Pharmaceutical (COLL) Q1 Earnings Meet EstimatesCollegium Pharmaceutical (COLL) delivered earnings and revenue surprises of 0% and 4.07%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?Zacks Investment Research · May 4, 2023

Why Target Shares Are Trading Lower By 14%? Here Are 56 Stocks Moving In Wednesday's Mid-Day SessionGainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 109% to $0.2115 after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process. InMed Pharmaceuticals Inc. (NASDAQ: INM) shares climbed 60.5% to $4.4613. InMed Pharmaceuticals advanced neurodegenerative disease program with Natural Sciences and Engineering Research Council of Canada alliance grant funding. Tiga Acquisition Corp. (NASDAQ: TINV) gained 35.1% to $13.75. Exagen Inc. (NASDAQ: XGN) jumped 29% to $3.86. Exagen reported better-than-expected Q3 EPS and sales results and issued FY22 revenue guidance above estimates. Lizhi Inc. (NASDAQ: LIZI) gained 18% to $0.85 after the company swung to a profit for the third quarter. Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) surged 16.8% to $4.64. Reviva Pharmaceuticals recently posted a Q3 loss of $0.18 per share. REE Automotive Ltd. (NASDAQ: REE) gained 16.3% to $0.8139 as the company reported a third-quarter FY22 net loss of $(33.5) million versus a net loss of $(414.9) million the previous year. Chemomab Therapeutics Ltd. (NASDAQ: CMMB) rose 15.4% to $2.40. Chemomab Therapeutics recently posted a Q3 loss of $0.04 per share. Sportradar Group AG (NASDAQ: SRAD) shares climbed 15.3% to $11.70 after the company reported better-than-expected Q3 sales and raised FY22 revenue outlook. Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) gained 15.2% to $0.5702. Tonix Pharmaceuticals recently posted a Q3 loss of $0.69 per share. Atento S.A. (NYSE: ATTO) rose 14.9% to $4.39. Atento posted Q3 EPS of $0.10. AirSculpt Technologies, Inc. (NASDAQ: AIRS) surged 14.5% to $3.54. Cartesian Growth Corporation (NASDAQ: GLBL) rose 14.5% to $11.65. Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) gained 13.5% to $0.6139 after the company announced it signed a commercial agreement with SUNWAY-AI for up to $51 million. Consolidated Water Co. Ltd. (NASDAQ: CWCO) gained 13.4% to $15.53. Janney Montgomery Scott upgraded Consolidated Water from Neutral to Buy and announced a $20 price target. Natera, Inc. (NASDAQ: NTRA) gained 12.6% to $38.47. Natera priced follow-on offering of 11.4 million shares at $35 per share. Marker Therapeutics, Inc. (NASDAQ: MRKR) ...Benzinga · Nov 16, 2022

Journey Medical Corporation (DERM) Reports Q3 Loss, Misses Revenue EstimatesJourney Medical Corporation (DERM) delivered earnings and revenue surprises of -67.65% and 11.59%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?Zacks Investment Research · Nov 10, 2022

XBIOXenetic Biosciences, Inc.

XBIO

Pay with—

Start Trading

Available Balance0.00

Your PositionYou don't own any XBIO yet.

Related Tickers

Earnings

Volume

17.51K

Next Earnings

November 11th